NR3C1 and chronic obstructive pulmonary disease: The mechanism of resistance to corticosteroids in this group is not completely understood but appears to reflect prolonged inflammation, predominantly due to T-helper 2 cytokines, leading to specific alterations in the cellular glucocorticoid receptor (GR) [32, 33], which have not been described in COPD.